Genworth Financial, Inc. (GNW) Stock Price & Analysis
Genworth Financial, Inc. (GNW) closed at USD 9.03 on Thursday, October 29, 2026, up 1.69% on the day. The US market is currently closed (after-hours); this is not a live price.
The prior close was USD 8.88; the Oct 29, 2026 session ranged USD 8.94–9.07 on volume of 1,745,849 shares. Market capitalization is $3.41B, with a 52-week range of USD 7.84–10.69 (NYQ). Source: Nexqual, retrieved October 29, 2026 at 21:31 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GNW.md
Key facts (GNW)
- Last four reported quarters (through Jun 30, 2026): revenue $7.40B, net income $212M (2.9% margin) (SEC filings).
- Valuation: P/E 16.1x (avg 22.9x at the last 3 fiscal year-ends), net cash $486M.
- Insider open-market sales, last ~7 months: 5 Form 4 filings, $3.0M; 5 not under a Rule 10b5-1 plan ($3.0M); 2 by opportunistic insiders (2 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 10.5 (range 10.5–10.5).
- Total return with dividends: 1Y +7.2% vs S&P 500 +14.4%; 5Y +119.7% vs S&P 500 +79.1%.
- Next earnings: 2026-11-04, EPS estimate USD 0.27, revenue estimate $0K.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (GNW)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.82B | $7.50B | $7.49B | $7.29B | $7.30B | $7.40B |
| Operating income | $474M | $818M | $41.0M | — | — | — |
| Net income | $850M | $916M | $76.0M | $299M | $223M | $212M |
| EPS (diluted) | $1.65 | $1.79 | $0.16 | $0.68 | $0.54 | — |
| Operating margin | 6.1% | 10.9% | 0.5% | — | — | — |
| Net margin | 10.9% | 12.2% | 1.0% | 4.1% | 3.1% | 2.9% |
| Revenue growth | -5.6% | -4.2% | -0.1% | -2.6% | +0.1% | — |
| Cash + short-term investments | $1.57B | $1.80B | $2.21B | $2.05B | $2.04B | — |
| Total debt | $1.90B | $1.61B | $1.58B | $1.52B | $1.51B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (GNW)
P/E 16.1x · P/S 0.5x · EV/Sales 0.4x · P/B 0.4x · Earnings yield 6.21% · Buyback yield (TTM) 8.79% · Net cash $486M · EV $2.93B
P/E at fiscal year-ends: Dec 2025 16.8x, Dec 2024 10.3x, Dec 2023 41.7x.
Insider sales (SEC Form 4, open-market, last ~7 months) (GNW)
0 of 5 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | McInerney Thomas J | President and CEO; Director | 100,000 | $1.1M | 1.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-08-24 | Hagerman Melissa | EVP and Chief HR Officer | 14,708 | $146K | 7.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-21 | Karawan Gregory S. | EVP and General Counsel | 40,000 | $396K | 10.3% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-22 | McInerney Thomas J | President and CEO; Director | 100,000 | $927K | 1.8% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-22 | Restrepo Robert P Jr | Director | 50,000 | $456K | 35% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (GNW)
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 10.5 (low 10.5, high 10.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-09 | Keefe, Bruyette & Woods | Downgrade | Outperform → Market Perform | $11.5 → $10.5 |
| 2026-09-16 | Keefe, Bruyette & Woods | Target lowered | Outperform | $12 → $11.5 |
| 2026-07-13 | Keefe, Bruyette & Woods | Target raised | Outperform | $11 → $12 |
Total return (dividends reinvested) (GNW)
| 1Y (from 2025-10-30) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +7.2% | +119.7% |
| S&P 500 (SPY) | +14.4% | +79.1% |
| Per year | +7.3% | +17.0% |
| Volatility (annualized) | 23.1% | 32.1% |
| Max drawdown | -16.8% (Sep 2026→Oct 2026) | -24.1% (Feb 2023→Mar 2023) |
GNW earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Aug 5, 2026 | Quarter ended Jun 30, 2026 | $0.29 | $0.27 | Beat +7.4% | -1.0% |
| May 5, 2026 | Quarter ended Mar 31, 2026 | $0.28 | $0.20 | Beat +40.0% | +3.4% |
| Feb 23, 2026 | — | — | — | — | -2.6% |
| Feb 3, 2026 | — | — | — | — | +5.2% |
| Nov 5, 2025 | Quarter ended Sep 30, 2025 | $0.04 | $0.05 | Miss −20.0% | +0.7% |
| Jul 30, 2025 | — | — | — | — | -1.7% |
| Apr 30, 2025 | — | — | — | — | -1.2% |
| Feb 18, 2025 | — | — | — | — | -7.5% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
GNW recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 13, 2026 | 8-K | Director or executive officer change, or pay arrangement “On October 8, 2026, Darren W. Woodell, Vice President and Controller (Principal Accounting Officer) of Genworth Financial, Inc. (the "Company") notified the Company of his intent to resign to pursue a new opportunity, effective in early November 2026 following the filing of the Company's Form 10-Q for the period ending September 30, 2026. Mr. Woodell will continue to serve in his current role until such time. Mr. Woodell's resignation is not a result of any disagreement with the Company on any matter relating to…” |
| Aug 20, 2026 | 8-K | Director or executive officer change, or pay arrangement “On August 20, 2026, Genworth Financial, Inc. (the "Company") announced that Thomas J. McInerney will return from a leave of absence and resume the role of President & Chief Executive Officer, effective September 2, 2026. In connection with Mr. McInerney's return, he will resume day-to-day operational responsibilities and the role of principal executive officer of the Company. Accordingly, Jerome T. Upton, who has been serving as the Company's Interim President and Chief Executive Officer (Principal Executive…” |
| Aug 11, 2026 | Schedule 13G | DONALD SMITH & CO., INC., DSCO Value Fund, L.P.: 5.9% of shares, passive 5%+ holder |
| Aug 6, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Aug 5, 2026 | 8-K | Quarterly results |
| Jul 7, 2026 | 8-K | Director or executive officer change, or pay arrangement “On July 7, 2026, Genworth Financial, Inc. (the "Company") announced that Thomas J. McInerney, President & Chief Executive Officer, will be taking a temporary leave of absence from his role to focus on his health. In connection with Mr. McInerney's leave of absence, the Company announced that Jerome T. Upton, the Company's current Executive Vice President and Chief Financial Officer (Principal Financial Officer), has been appointed Interim President and Chief Executive Officer (Principal Executive Officer),…” |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
GNW revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Closed Block | $1.53B | 80.7% | +2.0% |
| Enact | $319.0M | 16.8% | +2.2% |
| Total revenue | $1.90B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
GNW suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Enact Holdings, Inc. (ACT) | “For information on the potential impacts due to customer concentration, see "Item 1A—Risk Factors—Changes in the composition of Enact Holdings' business or undue concentration by customer or geographic region could cause a significant loss of business or adverse performance of a small segment of its portfolio."” |
Quoted from the company's 10-K filed Feb 27, 2026.
Companies that name GNW in their SEC reports
| Relationship to GNW | Company | Filing | Sentence |
|---|---|---|---|
| partner | Enact Holdings, Inc. (ACT) | 10-K Feb 27, 2026 | “We also have entered into a registration rights agreement with Genworth, which will give Genworth a right, subject to certain conditions, to require us to register the sale of our common stock beneficially owned by Genworth.” |
GNW company outlook (results filed Aug 5, 2026)
- “Through its family of brands—including CareScout, Genworth, and Enact—Genworth uses its more than 150 years of experience to help families navigate the aging journey with clarity and confidence, offering guidance, products, and services that support caregiving decisions, long-term care planning, and the financial challenges of aging.”
Quoted word-for-word from the SEC 8-K results press release.
GNW analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.27 | $0.07 | +285.7% | $0 | 1 |
| Next quarter (ends Dec 2026) | $0.26 | $0.07 | +271.4% | $0 | 1 |
| Current fiscal year (ends Dec 2026) | $1.10 | $0.41 | +168.3% | $0 | 1 |
| Next fiscal year (ends Dec 2027) | $1.10 | $0.36 | +205.6% | $0 | 1 |
GNW options: expected move
Options price a move of about ±7.0% (±$0.63) by Nov 20, 2026, which includes earnings on Nov 4, 2026. Over the last 8 reports the stock moved ±2.9% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 22 | 34.4% | ±7.0% |
| Dec 18, 2026 | 50 | 27.9% | ±8.4% |
| Jan 15, 2027 | 78 | 27.7% | ±10.4% |
| Mar 19, 2027 | 141 | 28.7% | ±14.4% |
| Jun 17, 2027 | 231 | 30.5% | ±19.4% |
30-day implied volatility 32.9% vs 27.5% realized over the last 30 trading days. Put/call ratio (volume) 0.23. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 21:31 UTC)
| Price | USD 9.03 |
|---|---|
| Change | ▲ 1.69% (up) |
| Previous Close | USD 8.88 |
| Open | USD 8.9 |
| Day Range | USD 8.94 – 9.07 |
| 52-Week Range | USD 7.84 – 10.69 |
| Volume | 1,745,849 shares |
| Market Cap | $3.41B |
| Exchange | NYQ |
Technical Analysis (GNW)
Nexqual's technical model rates GNW "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 29, 2026 at 21:31 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.23 (neutral) |
| vs SMA50 | Below (USD 9.61) |
| MACD | -0.2 (negative) |
Analyst Ratings (GNW)
Wall Street analysts rate GNW "Hold" based on 1 analysts, with a mean price target of USD 10.5 (range USD 10.5–10.5), per Nexqual as of October 29, 2026 at 21:31 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 10.5 |
| High Target | USD 10.5 |
| Low Target | USD 10.5 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (GNW)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.27 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.29 vs est 0.27 ▲ beat |
| 2026-03-31 | USD 0.28 vs est 0.2 ▲ beat |
| 2025-09-30 | USD 0.04 vs est 0.05 ▼ miss |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Financials & Fundamentals (GNW)
| Total Revenue | $7.38B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.30% |
| Gross Margin | +6.63% |
| Operating Margin | +7.25% |
| Profit Margin | +2.87% |
| ROE | +3.40% |
| Debt / Equity | 0.23 |
| Current Ratio | 10.68 |
| Total Cash | $2.07B |
| Total Debt | $2.28B |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Financial Health Score (GNW)
Nexqual rates Genworth Financial, Inc.'s overall financial health "Mixed" across five dimensions, as of October 29, 2026 at 21:31 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $1.99B cash and investments vs $1.50B debt (Jun 2026, SEC), net cash |
| Cash Flow | Solid — Operating cash flow $327M (FY ended Dec 2025, 10-K) |
| Efficiency | Weak — ROE 2%, ROA 0.2% (last 4 quarters, SEC) |
Ownership (GNW)
| Insider Ownership | +1.83% |
|---|---|
| Institutional Ownership | +90.30% |
| Shares Outstanding | 377.85M |
| Float | 369.17M |
| Short % of Float | +3.42% |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Leadership (GNW)
Genworth Financial, Inc. is led by Thomas Joseph McInerney, President, CEO & Director, per Nexqual as of October 29, 2026 at 21:31 UTC.
| President, CEO & Director | Thomas Joseph McInerney |
|---|---|
| Executive VP & CFO | Jerome Thomas Upton |
| President & CEO of Genworth Insurance | Jamala Murray Arland |
| President & CEO of CareScout | Samir Bhupendra Shah |
Major Backers & Investors (GNW)
Notable institutional backers of Genworth Financial, Inc. include Donald Smith & Co., Inc., River Road Asset Management, LLC, American Century Companies Inc, according to Nexqual as of October 29, 2026 at 21:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Donald Smith & Co., Inc. | 5.95% |
| River Road Asset Management, LLC | 3.83% |
| American Century Companies Inc | 3.05% |
| Fidelity | 1.75% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 14.79% |
| Vanguard Group | 10.27% |
| Dimensional Fund Advisors | 6.78% |
| State Street | 4.38% |
| Nuveen | 2.96% |
| Geode Capital | 2.71% |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
From Genworth Financial, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- CareScout Services made significant progress during 2025, expanding its network of care providers ("CareScout Quality Network") to approximately 790 home care providers with more than 1,000 locations nationwide, and continued to see growth in the number of CareScout members who received first-time services from the network.
- Excluding the payment to acquire Seniorly, we contributed approximately $50 million to CareScout Services in 2025.
- Enact's loss mitigation and claims department is led by seasoned personnel who are supported by default tracking and claims processing capabilities within their integrated platform.
- The capital was used to scale our technology-enabled platform, along with marketing and brand awareness, as we seek to position the business for sustainable long-term growth.
Partnerships
- In September 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $350 million of its outstanding common stock.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes in accounting and reporting standards issued by the Financial Accounting Standards Board or other standard-setting bodies and insurance regulators could materially adversely affect our business, financial condition and results of operations.
- The inability to execute in-force management actions (including obtaining in-force rate actions) on our long-term care insurance products in Closed Block could have a material adverse impact on our business, including our results of operations and financial condition.
- Our insurance businesses are extensively regulated and changes in regulation may reduce our profitability and limit our growth.
- Litigation and regulatory investigations or other actions are common in the insurance business and may result in financial losses and harm our reputation.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FG | F&G Annuities & Life, Inc. | USD 21.05 | ▲ 2.18% |
| BHF | Brighthouse Financial, Inc. | USD 42.98 | ▼ 1.89% |
| CNO | CNO Financial Group, Inc. | USD 55.17 | ▲ 1.45% |
| LNC | Lincoln National Corporation | USD 41.37 | ▲ 1.75% |
| PRI | Primerica, Inc. | USD 283.55 | ▲ 1.61% |
| JXN | Jackson Financial Inc. | USD 135.97 | ▲ 1.09% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 21:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt